Trim-Lok Helps Hospital Acquire Ventilator
Several years ago, Gary Whitener, CEO of Trim-Lok Inc. in Buena Park, Calif., had some ground-breaking surgery performed. He was one of the first patients to have a heart valve replaced with a cow’s valve by cardiologist Dr. Subbarao Myla. So, when Myla recently had a special request for Whitener, the businessman didn’t hesitate to help.
Whitener donated $10,000 to Hoag Memorial Hospital Presbyterian of Newport Beach, Calif., for the purchase of a ventilator.
During the global COVID-19 pandemic the importance of all medical facilities being able to access needed equipment is vital to the health and safety of communities, patients, doctors and staff.
After a conversation with Myla about the hospital’s needs, Whitener immediately made the generous contribution.
“Dr. Myla is more than just my cardiologist, he is also a good friend,” Whitener said. “He knows the importance of having enough ventilators during this coronavirus pandemic and reached out to me to discuss the need for more ventilators at Hoag. I didn’t need to think twice about helping. We are living in unprecedented times and I am honored to donate to such a wonderful hospital.”
Trim-Lok supplies thermoplastic and thermoset rubber profile extrusions to the RV industry.
For nearly 50 years, the company’s processing methods have enabled it to meet the requirements for top quality plastic and rubber trim and seal parts.
Its team can design parts and tooling, and then fabricate them to exact specifications ensuring performance and value. The company adheres to strict quality-control standards and invests in modern equipment and highly skilled employees who are experienced in all phases of manufacturing and production so that you can count on reliability, efficiency and repeatability.
For 67 years, Hoag Memorial Hospital Presbyterian has delivered personalized care in Orange County. Since 1952, Hoag has served the local communities and continues its mission to provide the highest quality health-care services through the core strategies of quality and service, people, physician partnerships, strategic growth, financial stewardship, community benefit and philanthropy.
Myla is the medical director of Cardiac and Endovascular Labs and Cardiovascular Research at Jeffrey M. Carlton Heart and Vascular Institute at Hoag Hospital Newport Beach and the Dr. Joel H. Manchester Endowed Chair in Interventional Cardiology.
Myla leads the clinical direction of endovascular therapy and cardiovascular research at Hoag Heart and Vascular Institute.
Under his leadership, Hoag has initiated more than 25 FDA-regulated clinical trials investigating a variety of innovative medical devices and procedures, all of which focus on stroke prevention. Hoag is one of only a handful of medical facilities in the western U.S. to participate in these studies.